Successfully addressing PC-NDTs (which rely on preventive chemotherapy treatments) continues to rely on community drug distributors. Given contemporary modern health regulations, there may be a lower population of volunteers willing to support MDA campaigns. Distribution chains need to reevaluate human capacity needs to determine the appropriate approach to restart activities.